Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
- PMID: 34935000
- PMCID: PMC8676416
- DOI: 10.1016/S2666-7568(21)00304-4
Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
Conflict of interest statement
We declare no competing interests.
Comment on
-
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.Lancet Healthy Longev. 2022 Jan;3(1):e13-e21. doi: 10.1016/S2666-7568(21)00282-8. Epub 2021 Dec 16. Lancet Healthy Longev. 2022. PMID: 34935001 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous